Pharmafile Logo

B2B sales

- PMLiVE

Regeneron’s Dupixent and Praluent falls short

But CEO Len Schleifer says there’s time to fix that

- PMLiVE

Gamida Cell strengthens leadership team

Appoints Josh Hamermesh and Paul Nee

- PMLiVE

AXON appoints new head of medical communications

Emma Lemon will be based in its London, UK office

- PMLiVE

Random42 wins Queen’s Award for Enterprise

Will celebrate during the royal reception this summer

- PMLiVE

FDA looks to regulate digital tools

US regulator adds new components to digital health plan

- PMLiVE

Leo has its eyes on the prize

The company looks to the future as it bids to find novel ways to manage and defeat debilitating skin conditions

- PMLiVE

Novo Nordisk fends off Lilly’s GLP-1 challenge in Q1

Insulin specialist bounces back with encouraging signs from Ozempic launch

- PMLiVE

J&J pays $140m upfront for cancer-busting virus firm BeneVir

The total value of the deal could go above $1bn if the biotech’s candidates perform well

- PMLiVE

Profit: the ugly, dirty truth?

“My shareholders expect me to make the most profit. That's the ugly, dirty truth.”

Pharnext appoints COO

Amit Kohli joins the biopharma from Eurofins

- PMLiVE

Incisive Health adds to its team

Maddy Farnworth and Tom Stephens join the consultancy

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links